The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects

Journal:
Journal of Clinical Investigation
Published:
DOI:
10.1172/jci138332
Affiliations:
9
Authors:
20
Institutions Authors Share
Amsterdam UMC, Netherlands
8.000000
0.40
Accure Therapeutics S.L., Spain
4.000000
0.20
DZNE Site Magdeburg, Germany
3.000000
0.15
Center for Neuroscience, Netherlands
2.000000
0.10
UCL, United Kingdom (UK)
1.000000
0.05
University of Bonn (Uni Bonn), Germany
1.000000
0.05
University of Amsterdam (UvA), Netherlands
1.000000
0.05